Preclinical antitumor activity of ST7612AA1: a novel second generation oral histone deacetylase (HDAC) inhibitor

ABSTRACT: assess the efficacy of ST7612AA1 oral pan-histone deacetylase inhibitor (HDACi), with respect to various solid and haematological tumors, and to characterize its mechanism of action

ORGANISM(S): Homo sapiens

PROVIDER: GSE62460 | GEO | 2015/03/18

SECONDARY ACCESSION(S): PRJNA264171

REPOSITORIES: GEO